Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes

Table 3 Associations between AMH (ng/dl) and levels of concurrent cardiovascular disease risk factors and renal function (n = 390 women with n = 781 observations)

	Unadjusted	Adjusted for age and medication use^a
Systolic blood pressure (mm Hg)	−0.32 (−0.60, −0.03)	0.005 (−0.29, 0.30)
Diastolic blood pressure (mm Hg)	−0.01 (−0.21, 0.18)	0.11 (−0.10, 0.31)
Total cholesterol (mg/dl)	−0.21 (−0.95, 0.53)	−0.02 (−0.81, 0.77)
Low-density lipoprotein cholesterol (mg/dL)	0.02 (−0.63, 0.66)	0.02 (−0.66, 0.71)
High-density lipoprotein cholesterol (mg/dL)	−0.14 (−0.44, 0.16)	−0.05 (−0.37, 0.28)
Triglycerides (mg/dL)	−0.25 (−1.22, 0.73)	−0.10 (−1.16, 0.85)
Log albumin excretion ratio (mg/day)	0.02 (−0.003, 0.04)	0.01 (−0.01, 0.04)
Estimated glomerular filtration rate (mL/min/1.73 m²)	0.57 (0.25, 0.88)	0.02 (−0.29, 0.34)
Waist circumference (cm)	−0.11 (−0.34, 0.12)	−0.05 (−0.29, 0.20)

^aAntihypertensive medication use for systolic and diastolic blood pressure, log AER, eGFR, and lipid-lowering medication use for total cholesterol, LDL, HDL, and triglycerides. Age was the only adjustment made in the waist circumference model
Beta-coefficients and 95% confidence intervals shown from repeated measures regression models. Each beta-coefficient is per 1 ng/dl increment in AMH

ISSN: 2054-2690